AAV8-mediated gene therapy of Pompe mice normalizes muscle pathology and corrects motor function deficits

被引:0
|
作者
Cheng, S. H. [1 ]
Zhao, M. A. [1 ]
Bercury, S. [1 ]
Fidler, J. A. [1 ]
Foley, J. W. [1 ]
Ryan, S. [1 ]
Taksir, T. [1 ]
Shihabuddin, L. S. [1 ]
Ziegler, R. J. [1 ]
机构
[1] Genzyme Corp, Framingham, MA 01701 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:30 / 30
页数:1
相关论文
共 50 条
  • [41] AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice
    Chen, Hsin-Hsiung
    Yeo, Hsin-Tung
    Huang, Yun-Hsin
    Tsai, Li-Kai
    Lai, Hsing-Jung
    Tsao, Yeou-Ping
    Chen, Show-Li
    SKELETAL MUSCLE, 2024, 14 (01):
  • [42] Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid α-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice
    Ziegler, Robin J.
    Bercury, Scott D.
    Fidler, Jonathan
    Zhao, Michael A.
    Foley, Joseph
    Talsir, Tatyana V.
    Ryan, Susan
    Hodges, Bradley L.
    Scheule, Ronald K.
    Shihabuddin, Larnya S.
    Cheng, Seng H.
    HUMAN GENE THERAPY, 2008, 19 (06) : 609 - 621
  • [43] Systemic AAV-Mediated Gamma-Sarcoglycan Therapy for Treatment of Muscle Deficits in LGMD2C Mice
    Pozsgai, Eric R.
    Peterson, Ellyn L.
    Griffin, Danielle A.
    Mendell, Jerry R.
    Rodino-Klapac, Louise R.
    MOLECULAR THERAPY, 2019, 27 (04) : 13 - 13
  • [44] Long-Term Rescue of a Hypomorphic Lethal Murine Model of Citrullinemia Type I by Liver-Directed, AAV8-Mediated Gene Therapy
    Wang, Lili
    White, John
    He, Zhenning
    McMenamin, Deirdre
    Wilson, James M.
    MOLECULAR THERAPY, 2017, 25 (05) : 114 - 114
  • [45] AAV2/8-MEDIATED GENE THERAPY PROVIDES PROLONGED PROTECTION AGAINST BIOCHEMICAL INDUCTION OF ACUTE ATTACKS AND IMPROVES MOTOR FUNCTION IN ACUTE INTERMITTENT PORPHYRIA MICE
    Yasuda, M.
    Bishop, D. F.
    Fowkes, M. E.
    Cheng, S. H.
    Gan, L.
    Desnick, R. J.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 139 - 139
  • [46] A phase 1/2 clinical trial for AAV8-mediated liver-directed gene therapy in adults with late-onset OTC deficiency
    Geberhiwot, T.
    Aldamiz-Echevarria, L.
    Couce, M. L.
    Harding, C. O.
    Khan, A.
    Tan, W. H.
    Lin, J.
    Crombez, E.
    Diaz, G. A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A59 - A59
  • [47] Nutritional changes after an AAV8-mediated liver-directed gene therapy in adults with glycogen storage disease type Ia (GSD Ia)
    Saavedra, H.
    Mount, M.
    Lipinski, S.
    Camba-Garea, M-J
    de Boer, F.
    Boney, A.
    Rodriguez-Buritica, D. F.
    Riba-Wolman, R.
    Ahmad, A.
    Couce Pico, M. L.
    Derks, T. G.
    Mitchell, J. J.
    Mitragotri, D.
    Grimm, A. A.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 : 29 - 29
  • [48] Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa)
    Weinstein, David A.
    Derks, Terry G.
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    Couce, Maria-Luz
    Mitchell, John J.
    Riba-Wolman, Rebecca
    Mount, Malaya
    Sallago, Julieta Bonvin
    Ross, Katalin M.
    van Der Klauw, Melanie M.
    de Boer, Foekje
    van Der Schaaf, Caroline
    Saavedra, Heather
    Martinez-Olmos, Miguel
    Atanga, Elvis
    Hosseini, Asad
    Mitragotri, Deepali
    Crombez, Eric
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (02)
  • [49] Therapeutic Correlation of Neurological Deficits and Brain Inflammation with Windows of Treatment by AAV-Mediated Gene Therapy in Gaucher Disease Mice
    Lin, Yi
    DeMott, Jacob
    Zhang, Zhenting
    Wang, Xiaohong
    Liou, Benjamin
    Sun, Ying
    Xiao, Weidong
    Pan, Dao
    MOLECULAR THERAPY, 2020, 28 (04) : 118 - 118
  • [50] Systemic dose-finding study with AAV-Mediated gamma-sarcoglycan gene therapy for treatment of muscle deficits in LGMD2C Mice
    Seo, Y.
    Kempton, A.
    Rogers, O.
    Baine, S.
    Lewis, S.
    Adegboye, K.
    Haile, A.
    Griffin, D.
    Peterson, E.
    Pozsgai, E.
    Rodino-Klapac, L.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S87 - S87